Avrobio Company
Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Funding Status:
IPO
Headquarters:
Cambridge, Massachusetts, United States
Industry:
Gene Therapy
Estimated Revenue:
$10M to $50M
Technology:
Cancer
Founded Date:
2015